About SpaceOAR hydrogel
SpaceOAR hydrogel is a Healthcare company based in Bedford (United States) founded in 2007, and was acquired by Boston Scientific in October 2018. Rectal protection hydrogel for prostate cancer radiation therapy is provided. SpaceOAR hydrogel has raised $13.88 million across 3 funding rounds from investors including Boston Scientific. Its chief executive, as recorded, is John Pedersen. SpaceOAR hydrogel offers products and services including SpaceOAR Hydrogel. Its focus areas include Life Sciences, Imaging Diagnostics and Accessories. Its legal entity is Boston Scientific Corporation. Its competitors include Lucerno Dynamics, Quality Electrodynamics and m2m Imaging Corp; 2 of its 3 listed competitors have raised funding.
Company details
SpaceOAR hydrogel was established in 2007 in Bedford, United States, within the medical device sector focused on oncology. A hydrogel spacer is offered by the company to create separation between the prostate and rectum during radiation therapy procedures. This minimally invasive intervention is designed to minimize rectal injury risks. Operations center on the development and provision of this protective system for prostate cancer treatments.
- Headquarters Bedford, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website spaceoar.com/us/en/home.html
- Social LinkedIn X Facebook
- Acquired by Boston Scientific (Oct 2018)
- Legal Name Boston Scientific Corporation
- Total Equity Funding$13.88M (USD)
in 3 rounds
- Latest Funding Round$10.88M (USD), Series B
Jul 2014
- Investors
- Acquired byBoston Scientific
(Oct 2018)
Products & Services of SpaceOAR hydrogel
SpaceOAR hydrogel offers a comprehensive portfolio of products and services, including SpaceOAR Hydrogel.
Hydrogel spacer that protects rectum during prostate radiation therapy sessions.
Funding Insights of SpaceOAR hydrogel
SpaceOAR hydrogel has successfully raised a total of $13.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10.88 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.88M
- Total Rounds 3
- Last Round Series B — $10.88M
All 3 funding rounds of SpaceOAR hydrogel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $10.88M | Series B | – | – | – |
| Nov 2010 | $3M | Series A | – | – | – |
| Nov 2010 | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in SpaceOAR hydrogel
SpaceOAR hydrogel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for SpaceOAR hydrogel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SpaceOAR hydrogel
1 people are tracked at SpaceOAR hydrogel (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Pedersen | CEO & President | Leadership |
Complete people profiles for SpaceOAR hydrogel
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SpaceOAR hydrogel
4 dated milestones of SpaceOAR hydrogel across 11 years, from founding to its latest funding, stage changes and deals.
- Founded SpaceOAR hydrogel is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $10.9M.
- Exit Acquired by Boston Scientific.
Competitors of SpaceOAR hydrogel
SpaceOAR hydrogel has 3 listed competitors in our database, 2 of them funded. They include Lucerno Dynamics, Quality Electrodynamics and m2m Imaging Corp..
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lucerno.com | 2011 | Cary, United States | $6.34M | Imaging technology for radiotracer quality assessment is developed. | ||
| qedinnovations.com | 2006 | Cleveland, United States | 142 | Magnetic resonance equipment and accessories for clinical diagnosis | ||
| m2mimaging.com | 2006 | Cleveland, United States | $10.1M | Preclinical MRI Imaging Devices and Accessories |
Detailed competitors of SpaceOAR hydrogel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SpaceOAR hydrogel
The website of SpaceOAR hydrogel (spaceoar.com) receives about 6K visits a month.
- Monthly visits6K
▼ 13.2% vs previous month
Websites whose visitors overlap most with SpaceOAR hydrogel. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bostonscientific.com | 100% | 738.5K | #88,615 | View details | |
cancercare.org | cancercare.org | 60% | #422,307 | – | |
urologyhealth.org | urologyhealth.org | 60% | #123,619 | – | |
ancan.org | ancan.org | 31% | #1,871,500 | – | |
westernradiationoncology.com | westernradiationoncology.com | 30% | #7,589,263 | – |
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as SpaceOAR hydrogel (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spaceoar Hydrogel
Complete news archive for SpaceOAR hydrogel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpaceOAR hydrogel
SpaceOAR hydrogel was founded in 2007 and raised its 1st funding round 3 years after it was founded.
SpaceOAR hydrogel is headquartered in Bedford, United States.
John Pedersen is the CEO of SpaceOAR hydrogel, as recorded in our data.
SpaceOAR hydrogel is a funded company, having raised a total of $13.88M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Nov 2010.
SpaceOAR hydrogel was established in 2007 in Bedford, United States, within the medical device sector focused on oncology. A hydrogel spacer is offered by the company to create separation between the prostate and rectum during radiation therapy procedures. This minimally invasive intervention is designed to minimize rectal injury risks. Operations center on the development and provision of this protective system for prostate cancer treatments.
SpaceOAR hydrogel's top competitors include Quality Electrodynamics, Lucerno Dynamics and m2m Imaging Corp..
SpaceOAR hydrogel offers SpaceOAR Hydrogel.
SpaceOAR hydrogel has 1 investor. Key investors include Boston Scientific.
SpaceOAR hydrogel operates through Boston Scientific Corporation.
Yes. SpaceOAR hydrogel was acquired by Boston Scientific in October 2018.